Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Indosat Tbk. (ISAT) vs Organon Pharma Indonesia Tbk. (SCPI)

Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Indosat Tbk. dan Organon Pharma Indonesia Tbk.: Indosat Tbk. diperdagangkan di Rp2.430 (kapitalisasi pasar 77,4 T, volume 24 jam 93,15 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indosat Tbk. jauh lebih besar — sekitar 741,4× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

ISATSCPI
Kapitalisasi Pasar
77,4 T104,4 M
Volume
93,15 jt
Lot
931,49 rb
Perputaran
223,55 M
Harga Rata-rata
2.399,91
Nilai Transaksi
223,55 M
Harga Ekuilibrium Indikatif
2.430
Volume Ekuilibrium Indikatif
38,19 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ISAT
Lihat detail
SCPI
Lihat detail

Tentang Indosat Tbk.

Indonesian Satellite Corporation Tbk, PT (Persero), was established on November 10, 1967 within the framework of the Indonesian foreign Investment Law No. 1 of 1967. The company’s articles of association have been amended from time to time, most recently on Sept 4, 1997, concerning the changes in the articles of association to conform with Law No. 1 of 1995 on limited liability companies.

Selengkapnya di halaman ISAT

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI